Abstract. Prostacyclin synthase (PGIS or PTGIS) is an enzyme that catalyses the conversion of prostaglandin H 2 (PGH 2 ) to prostaglandin I 2 (PGI 2 ). PGI 2 promotes cancer growth by activating peroxisome proliferator-activated receptor δ (PPARδ), and increases the expression levels of the pro-angiogenic factor vascular endothelial growth factor (VEGF). We found that the expression of the PGIS gene was enhanced in WI-38, TIG-3-20 and HEL human lung fibroblast cells and two cancer cell lines (NB-1 and G361) under hypoxic conditions. The main localization of PGIS changed from the cytoplasm to the nucleus by hypoxia in WI-38 cells. The induced PGIS had an enzymatic activity since the intracellular level of 6-keto-prostaglandin, a useful marker of PGI 2 biosynthesis in vivo, was increased with the increasing levels of PGIS. Expression of VEGF was increased in parallel with PGIS induction under hypoxic conditions. PGIS knockdown resulted in the decreased expression of VEGF mRNA. Since VEGF is a known PPARδ target gene, we examined the effects of siRNAs targeting PPARδ on the expression of VEGF under hypoxic conditions. Knockdown of PPARδ suppressed the expression of VEGF under hypoxic conditions in WI-38 cells. These findings suggest that PGIS is induced by hypoxia and regulates the expression of VEGF in fibroblasts. Fibroblasts in the hypoxic area of tumors may have an important role in tumor growth and angiogenesis.
Introduction
Cancer is subject to a unique microenvironment, composed of cancer cells, cancer-associated stromal fibroblasts (CAFs), endothelial cells, inflammatory cells and abundant extracellular matrix (1) . It has been hypothesized that the components besides cancer cells in cancer tissues are functionally organized to promote survival of cancer cells against hypoxia in the host and generate a favorable microenvironment for cancer cells in both primary and metastatic sites (2) . CAFs in the tumor stroma are involved in all stages of tumor development. A previous study has shown that fibroblasts from cancer mass produce PGI 2 but fibroblasts from adjacent normal tissues do not (3) . However, how CAFs are activated to produce PGI 2 and if the activated CAFs can promote angiogenesis by generating VEGF itself are poorly understood.
We investigated the modulation of the gene expression in human fibroblasts under hypoxic condition using GeneChip analysis, and found that the expression of prostacyclin synthase (PGIS) was upregulated. PGIS, a membrane-bound heme protein with spectral characteristics of cytochrome p450 (CYP), is also an enzyme which catalyzes the conversion of prostaglandin H 2 (PGH 2 ) to form prostacyclin (PGI 2 ). PGIS is localized to the microsomal fractions of platelets, vascular endothelial cells, and vascular smooth muscle cells (4) (5) (6) (7) (8) . PGIS-deficient mice generated by gene targeting are associated with thickening of arterial walls, interstitial fibrosis with nephrosclerosis and kidney infarction (9) . Interestingly, some groups reported that PGI 2 , the product of PGIS, promotes colorectal cancer growth probably by activating peroxisome proliferator-activated receptor δ (PPARδ) (10) . Inhibition of COX-2-derived prostacyclin (PGI 2 ) induces colon cancer cell apoptosis (11) . PGI 2 also regulates the transcription of VEGF by PPARδ (12, 13) .
VEGF expression is augmented by hypoxia-induced PGIS in human fibroblasts
In the present study, we focused our study on PGIS and confirmed that the expression of PGIS was upregulated in human fibroblasts under hypoxic condition and the induced PGIS was involved in the induction of VEGF. We have suggested that PPARδ enhances the hypoxic induction of VEGF.
Materials and methods
Antibodies. The polyclonal antibody against PGIS was purchased from Cayman. The polyclonal antibody against Erk-1 was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The monoclonal antibody against GAPDH was purchased from Ambion Inc. (Austin, TX).
Patients. The paraffin specimens of 3 cases of colon cancer were supplied from Department of Surgical Oncology Kagoshima University Faculty of Medicine. This study was performed with the approval of the Ethics Committee for Epidemiological Studies in Kagoshima University Graduate School of Medical and Dental Sciences.
Cell lines and cell cultures. WI-38 and TIG-3-20 human fibroblasts were purchased from Health Science Research Resources Bank (HSRRB), human embryonic lung fibroblasts (HEL) and human neuroblastoma cells (NB-1) cell lines were provided from Professor Y. Eizuru (Kagoshima University, Kagoshima, Japan) and Professor A. Tomoda (Tokyo Medical University, Tokyo, China), respectively. Other cell lines were stocked in our laboratory. All of the cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% FCS, 2 mM glutamine and 100 U/ml penicillin at 37˚C in a 5% CO 2 humidified atmosphere. Hypoxic condition was induced by incubating the cells in a Personal Multigas Incubator (Astec) at 37˚C with humidified 1% O 2 .
GeneChip analysis. cDNA and biotinylated cRNA were synthesized according to the standard protocols provided by Affymetrix (Santa Clara, CA). Biotinylated cRNA were purified using the Sample Cleanup Module (Affymetrix), and subsequently hybridized, according to the manufacturer's standard protocols, to Affymetrix HGU133A GeneChips (which contain 22283 probe sets). Arrays were scanned using an Affymetrix confocal laser scanner. A gene expression analysis software program, GeneSpring, version 7.1 (Agilent), was used to perform statistical analysis.
Reverse transcription-PCR. 1 µg first-strand cDNA was used for each polymerase chain reaction (PCR). The human PGIS primers were as follows: forward, 5'-ctggctcctgc tcttccttctcaag-3'; reverse, 5'-caccacgtcgcaggttgaattcttg-3'. The human VEGF primers were: forward, 5'-tgtcttgggtgcattggag ccttgc-3'; reverse, 5'-gttgtgctgtaggaagctcatctctc-3'. The human GAPDH primers for internal control were: forward, 5'-tgcacc accaactgcttag-3'; reverse, 5'-gaggcagggatgatgttc-3'. The human PPARδ primers were: forward, 5'-actgagttcgccaagagcatc-3'; reverse, 5'-aacgttcatgaggcctggccg-3'.
The PCR amplification mixture was adjusted to a final volume of 20 µl. Twenty-eight cycles were performed at 94˚C for 30 sec for denaturation, 58˚C for 30 sec for annealing, and 72˚C for 30 sec for extension. The PCR products were separated on 1.5% agarose gel and then stained with ethidium bromide.
Real-time reverse transcription-PCR quantification. Total cellular RNA was extracted using TRIzol reagent according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). One microgram of RNA was reverse transcribed using a firststrand cDNA synthesis kit (ReverTra Ace-α-, Toyobo, Osaka, Japan). The set of SYBR Premix Ex Taq kit was purchased from Takara Bio (Shiga, Japan). Human PGIS, VEGF, GAPDH gene expression levels were assayed by real-time reverse PCR (PRISM 7900HT, Applied Biosystems, Foster City, CA) according to the technical brochure of the company. Human GAPDH was used for normalization. Quantification of target gene expression was obtained with the comparative cycle threshold method according to the instructions of the manufacturer (Applied Biosystems). All experiments were performed in triplicate for each data point. Each quantitation was performed with the standard curve method.
Protein extraction and immunoblot analysis. Cells were harvested and lysed with RIPA buffer [50 mM Tris-HCI (pH 7.4), 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 20 mM NaF, 100 mM Na 3 VO 4 , 0.5% Nonidet P-40 (NP-40), 1% Triton X-100, 1 mM PMSF, DTT, aprotinin, APMSF and protease inhibitor cocktail (Sigma)]. The lysates were passed through a 21-gauge needle to break up the cell aggregates and were cleared by centrifugation at 14,000 x g for 15 min at 4˚C; the supernatant (total cell lysate) was immediately used or stored at -80˚C until use.
Lysates were subjected to 9.4% SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and then were transferred to polyvinylidene difluoride membranes (Immobilon-P transfer membrane; Millipore, Bedford, MA). The membrane was treated with buffer A [350 mM NaCl, 10 mM Tris-HCl (pH 8.0), and 0.05% Tween-20] containing 3% skimmed milk for 1 h and incubated with the indicated antibody (1:1,000) in buffer A containing 3% skimmed milk for 1 hour. Following four washes with buffer A (10 min each), the membrane was incubated with a peroxidase-conjugated horse anti-mouse IgG diluted 1:1,000 in buffer A containing 3% skimmed milk for 1 hour. The membrane was washed with buffer A and developed using the enhanced chemiluminescence western blot analysis detection system (Amersham Biosciences, Buckinghamshire, UK).
Subcellular fractionation. Cells were washed with PBS and then resuspended in 3 volumes of buffer B [10 mM HEPES-KOH (pH 7.8), 10 mM KCl, 0.1 mM EDTA (pH 8.0), 1 µg/ml aprotinin and 1 mM p-aminophenyl methanesulfonyl fluoride]. The cells were disrupted by dounce homogenizer. The nuclear fractions were centrifuged at 13,000 rpm for 5 min at 4˚C. The supernatant was used as cytosolic fractions.
Inhibition of PGIS and PPARδ expression by small interfering
RNA. Specific small interfering RNA (siRNA) of PGIS was purchased from Santa Cruz Biotechnology. SiRNA duplexes of PPARδ were synthesized using the Silencer™ siRNA construction kit (Ambion Inc.). The siRNA used in this study consisted of a 21-nucleotide sense strand and a 21-nucleotide antisense strand with a two-nucleotide overhang at 3'-end. The sequences were: PPARδ-siRNA(1) sense 5'-CAUGGAGUGCCGGGUGUG CUU-3' starting at nucleotide 211 from AUG start codon of human PPARδ coding sequence. PPARδ-siRNA(1) antisense, 5'-GCACACCCGGCACUCCAUGUU-3'. PPARδ-siRNA(2) sense 5'-GCUGGAGUACGAGAAGUGUUU-3' starting at nucleotide 313 from AUG start codon of human PPARδ coding sequence. PPARδ-siRNA(2) antisense, 5'-ACACUUCUCG UACUCCAGCUU-3'.
Transfections were accomplished using Lipofectamine 2000 (Invitrogen), according to the manufacturer's protocol. After transfection, the cells were incubated under normoxic condition for 5 h, then changed with fresh DMEM and incubated under hypoxic condition until harvested at different time points. The effect of the siRNA on the expression of PGIS and VEGF was assessed using RT-PCR and real-time PCR, as described above.
6-Keto-prostaglandin F1α enzyme immunoassay. 6-Ketoprostaglandin F1α (stable hydrolysis product of PGI 2 ) was analyzed by specific enzyme immunoassay kit (EIA) (Assay Designs), following the manufacturer's instructions. Lysates were added to every well of the kit plate. The resulting values of 6-keto-prostaglandin F1α concentrations in the supernatant were normalized for lyses buffer.
Confocal fluorescence microscopy. WI-38 and HEL cells were cultured under normoxic or hypoxic condition for different time, and fixed with 4% paraformaldehyde (PFA) in PBS for 30 min at room temperature. After blocking with 5% normal goat serum in PBS/0.02% Tween-20, the cells were incubated with an antibody against PGIS (1:100) at 4˚C overnight. After washing thrice in PBS/0.02% Tween-20, the cells were incubated with secondary antibodies (antirabbit-FITC 1x100). Nuclei were stained by incubating cells with 6 µmol/l 4'6-diamidino-2-phenylindole (DAPI). The cells were observed using confocal fluorescence microscopy (FV500, Olympus Corporation).
Immunohistochemistry. Immunohistochemical studies for PGIS and HIF-1α were performed on formalin-fixed, paraffin-embedded surgical sections obtained from patients with colorectal cancer. Slides were deparaffinized in xylene and rehydrated in a graded alcohol series. To retrieve antigen, sections were heated in the citrate buffer pH 6.0 (Target retrieval solution, S1699, Dako, Carpinteria, CA) for 5 min at 121˚C by means of an autoclave. For detection and visualization, the retrieved antigens were reacted with the appropriate specific primary antibodies solution (diluted to 1:100) for 1 h and were visualized by means of a polymer method (ChemMate Envision, K5027, Dako) and colorimetric diaminobenzidine (DAB)-peroxide (H 2 O 2 ) reaction (DAB+ liquid system, K3468, Dako). Nuclear counterstaining was hematoxylin (ChemMate hematoxylin, S2020, Dako). These procedures were performed by an autostainer (Autostainer, Dako) with rinsing buffer warmed at 35˚C (14). The increased levels of some genes that are closely related to tumor growth, metastasis, endothelial cell biology, and TGF-β signaling pathway are shown.
Results
GeneChip analysis. GeneChip analysis was used for identifying the modulation of the gene expression in fibroblasts under hypoxic condition. A total of 234 genes were differentially expressed between fibroblasts under normoxic or hypoxic condition in this study. Relative to normoxic condition data profiling, 172 genes were upregulated and 62 genes were downregulated (3-fold change). Of 172 upregulated genes, genes related to tumor metastasis, endothelial cell biology and TGF-β signaling pathway etc. were included. Table Ι lists some upregulated genes in fibroblasts under hypoxic condition. Among these genes, we focused on PGIS, which showed 13.5-fold increased expression levels. Fig. 1A , the expression levels of PGIS gene were significantly enhanced in fibroblasts such as WI-38, TIG-3-20 and HEL time-dependently under hypoxic condition. To quantitate the mRNA expression levels of PGIS in fibroblasts, real-time quantitative RT-PCR was performed (Fig. 1B) . Moreover, the expression levels of PGIS in some human cancer cells were also investigated in this study. The time-dependently enhanced expression levels of PGIS under hypoxic condition were detected in human neuroblastomas (NB-1) (Fig. 1A and B) and human melanomas (G361), but not in glioblastomas (U251MG), pancreas cancer (MiapacaⅡ), non-small cell lung cancer (A549), KB/TP and EJ/TP cells (15) (data not shown). PGIS mRNA was not detected in human macrophages (U937 and THP1) under normoxic or hypoxic condition (data now shown). Since the enhanced expression levels of PGIS were not detected in fibroblasts cultured in the medium containing 1% FCS (data not shown), the induction of PGIS could not be attributed to the low nutrient condition. These results suggested that the enhanced expression of PGIS mRNA in fibroblasts and some cancer cells was induced by hypoxic condition.
Expression of mRNA for PGIS proteins determined by RT-PCR or real-time qualitative PCR. As shown in

Expression and intracellular localization of PGIS in fibroblasts and neuroblastomas.
We next examined expression levels of PGIS in fibroblasts (HEL) and neuroblastomas (NB-1) by western blot analysis (Fig. 1C) . Expression levels of PGIS protein in both cell lines were also enhanced time-dependently under hypoxic condition consistent with mRNA level. To identify the subcellular localization of PGIS induced by hypoxia, PGIS was observed using confocal fuorescence microscopy. As shown in Fig. 2A , the expressions of PGIS were mainly localized in the cytoplasm of WI-38 cells, and translocated to nuclei under hypoxic condition. Immunoblot analysis also showed that PGIS was translocated from cytoplasm to nuclei when the cells were cultured under hypoxic condition (Fig. 2B) .
The effect of PGIS knockdown on the induction of VEGF under hypoxic condition in fibroblasts. PGI 2 is known to increase the expression levels of the pro-angiogenic factor VEGF (16, 17) . To confirm that PGIS is involved in the enhanced expression of VEGF under hypoxic condition in fibroblasts, PGIS siRNA was used to knockdown the expression of PGIS. The induction of PGIS mRNA expression by hypoxia was considerably suppressed by PGIS siRNA (Fig. 3A) . PGIS knockdown resulted in the decreased expression of VEGF mRNA (Fig. 3B) . These results show that PGIS is required for the hypoxic induction of VEGF. The levels of PGIS in cytoplasm and nuclei under normoxic or hypoxic conditions. The cells were incubated under normoxic or hypoxic conditions for 48 h. Cytoplasmic or nuclear fractions were prepared and subjected to immunoblot analysis with a specific antibody against PGIS.
Expression of 6-keto-prostaglandin F1α in HEL and NB-1 cells under hypoxic condition.
Since PGI 2 is unstable, the level of the stable hydrolysis metabolite of PGI 2 , 6-keto-prostaglandin F1α was analyzed in HEL and NB-1 cells under hypoxic condition. The level of 6-keto-prostaglandin F1α was also significantly increased in a time-dependent manner under hypoxic condition compared with that under normoxic condition (p<0.05, triplicate determinations; Fig. 3C ).
The effect of PPARδ-targeting siRNAs on the expression of VEGF under hypoxic condition. It was previously reported that endogenous PGI 2 generation by co-expression of COX-2 and PGIS activated PPARδ (18) . Because the expression of COX-2 was not induced under hypoxic condition in fibroblasts and tumor cells (data not shown), we considered that PGI 2 produced by the hypoxia-induced PGIS entered the nuclei and interacted with PPARδ.
To examine whether PPARδ regulates the expression of VEGF, WI-38 cells transfected with PPARδ siRNA or green fluorescent protein (GFP) siRNA as a control were cultured under hypoxic condition. As shown in Fig. 4 , downregulation of PPARδ suppressed the expression of VEGF mRNA. These (C) Levels of 6-keto-prostaglandin in HEL and NB-1 under hypoxic condition. In HEL and NB-1, PGIS activity was measured by determining the production of 6-keto-prostaglandin F1α, a degradation product of PGI 2 . When cells were incubated under hypoxic condition, the PGIS activity was also increased in a time-dependent manner. The PGIS activity in HEL or NB-1 cells under hypoxic condition for 36 and 48 h was significantly increased compared with that under normoxic condition ( * p<0.05).
results indicate that PPARδ regulates transcription of VEGF in WI-38 cells.
Expression of PGIS in clinical patients by immunohistochemistry.
To determine whether PGIS is expressed in fibroblasts and cancer cells in clinical human tumor tissues, we examined 3 cases of human colon cancer tissues. As shown in Fig. 5 , PGIS was expressed in cancer cells and fibroblasts which are located in the deep layers of the intestinal wall but not in the surface layers (Fig. 5a-b) . Immunohistochemical staining of PGIS validated the induced expression of PGIS in fibroblasts under hypoxic condition in tumors (Fig. 5d ).
Discussion
In this study, we observed the induction of PGIS expression under hypoxic condition, and confirmed that the induced PGIS was, at least in part, responsible for the increased expression of VEGF in human fibroblasts. We showed that PGIS was induced in fibroblasts and cancer cells by hypoxia, but not in cells under low nutrient condition (Fig. 1) . PGIS was accumulated in the nuclei of fibroblasts under hypoxia, and the amount of 6-keto-PGF 1α was increased with increasing expression of PGIS, suggesting that PGI 2 was produced by the induced PGIS.
We considered that the increased PGI 2 was caused by the hypoxia-induced PGIS, since the expression of COX-2 was not induced under hypoxic condition in both fibroblasts and tumor cells (data not shown). PGI 2 has been shown to be a ligand for peroxisomal-proliferator-activated receptors (PPAR). It was previously reported that endogenous PGI 2 generation by co-expression of COX-2 and PGIS led to transcriptional activation of PPARδ (18) . Increased PPARδ augmented the transcription of its target genes such as VEGF (19) , PGI 2 is also known to increase the expression of VEGF in cultured lung fibroblasts (17) . PGI 2 seems to play an important role in generating VEGF and consequently angiogenesis and tumor growth. Therefore, we investigated VEGF expression in fibroblasts under hypoxic condition. VEGF was time-dependently induced under hypoxic condition in a manner similar to PGIS. Downregulation of PGIS suppressed the increased expression of VEGF under hypoxic condition, indicating that PGIS is involved in the regulation of VEGF expression under hypoxic condition (Figs. 3A, B and 4) . These results suggest that PGIS locates upstream of the VEGF gene in agreement with previous results (12, 13) .
The pro-angiogenic factor VEGF overexpressed in most cancer cells is part of the system that restores oxygen supply to tumor tissues when blood circulation is inadequate (20) . It is generally accepted that VEGF recruited by cancer cells acts on cancer mesenchyme-like endothelial and inflammatory cells to cause angiogenesis. VEGF induced by PGIS in fibroblasts under hypoxic condition may play an important role in the progression of carcinomas.
Moreover, the main localization of PGIS changed from cytoplasm to nuclei by hypoxia in human fibroblast cells (Fig. 2) . This finding suggested that PGIS itself may enter the nuclei, where it synthesizes PGI 2 to regulate the expression of VEGF (Fig. 6) . The mechanism of this nuclear translocation of PGIS remains to be uncovered.
Finally, the immunostaining patterns of tumors from clinical cancer patients were in accord with the data obtained from in vitro experiments (Fig. 5) . The PGIS-positive cancer cells and fibroblasts were only detected in the deep layers of the intestinal wall where is thought to be deficient in oxygen but not in the surface layers. These findings might support the view that PGIS is involved in tumor progression and angiogenesis under hypoxic condition. PGI 2 was previously shown to activate PPARδ leading to subsequent acceleration in intestinal tumor growth in Apc Min/+ mice (21) . Meanwhile, PGI 2 -mediated activation of PPARδ was implicated in negative growth of lung cancer cell lines (22) . The role of PGIS in tumor growth might be different in respective cells.
Transcriptional regulation of the PGIS gene has rarely been reported in the literature. Recently, Camacho et al defined the minimal PGIS promoter region responsive to hypoxia. However, it did not contain a putative hypoxia responsive element (HRE). Furthermore, they observed that knockdown of HIF-1α abrogated hypoxia-induced PGIS upregulation in human vascular cells, and suggested that PGIS transcriptional activity enhanced by hypoxia could be the results of the cooperative binding of several transcription factors to PGIS promoter (23) . Further study is needed to elucidate the molecular basis for the induction of PGIS by hypoxia. Figure 6 . Schematic pathway for hypoxia-induced VEGF expression via PGI 2 in human fibroblasts. In the pathway for prostaglandin synthesis, an enzyme named PGIS catalyses the conversion of PGH 2 to PGI 2 . Our study showed that the level of PGIS in nuclei was enhanced in human fibroblasts under hypoxic condition, and suggested that increased PGI 2 binds to PPARδ to augment the transcription of its target genes such as Vegf.
In conclusion, this study provides new and important information about PGIS induced in fibroblasts under hypoxic condition. Since PGIS is involved in the enhanced expression of VEGF under hypoxic condition in human fibroblasts, PGIS may be a novel target for antitumor angiogenesis therapy.
